About Thorne Sparkman
Form D filings for Octagon Therapeutics in 2024 list Thorne Sparkman as director.
Thorne Sparkman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thorne Sparkman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thorne Sparkman works with at each company, as listed on that company's latest Form D.
Octagon Therapeutics, Inc. · Form D, Feb 12, 2024
Isaac Stoner
President and director
RL
Ronald Lennox
Director